CBCSG10:A phase Ⅲ trail adjuvant capecitabine with standard chemotherapy for triple negative breast cancer  

出　　处：《Science Foundation in China》2020年第2期33-33,共1页中国科学基金（英文版）

摘　　要：With the support from the National Natural Science Foundation of China,the research team led by Prof.Shao ZhiMin(邵志敏)at the Department of Breast Surgery,Fudan University,Shanghai Cancer Center and the Department of Oncology,Shanghai Medical College,Fudan University,recently reported that adjuvant capecitabine with docetaxel and cyclophosphamide plus epirubicin significantly improved DFS in TNBC without new safety concerns.

关 键 词：SURGERY ADJUVANT CANCER 

分 类 号：R737.9[医药卫生—肿瘤]